UBE2F-SCLY: A Potential Drug Target and Biomarker (G100533179)

Target Name: UBE2F-SCLY

NCBI ID: G100533179

UBE2F-SCLY

Other Name(s): UBE2F-SCLY readthrough (NMD candidate)

UBE2F-SCLY: A Potential Drug Target and Biomarker

Uncovering New Targets and Biomarkers for Cancer Treatment

Cancer is a leading cause of death worldwide, with over 20 million new cases

Protein Name: UBE2F-SCLY Readthrough (NMD Candidate)

The "UBE2F-SCLY Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBE2F-SCLY comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets